Prime; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Prime; Michael.The latest application filed is for "kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof".

Company Profile

4.19.20

Prime; Michael - Abingdon GB
Prime; Michael - Oxfordshire N/A GB
Prime; Michael - Oxon GB
Prime; Michael - Abington GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 10,501,433 - Dominguez , et al. Dec	2019-12-10
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 10,442,782 - Toledo-Sherman , et al. Oc	2019-10-15
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 10,428,054 - Toledo-Sherman , et al. October 1, 2	2019-10-01
Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20190047977 - Dominguez; Celia ; et al.	2019-02-14
Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20180222838 - Toledo-Sherman; Leticia M. ; et al.	2018-08-09
Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20180215745 - Toledo-Sherman; Leticia M. ; et al.	2018-08-02
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 9,981,918 - Toledo-Sherman , et al. May 29, 2	2018-05-29
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 9,938,252 - Dominguez , et al. April 10, 2	2018-04-10
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 9,884,853 - Toledo-Sherman , et al. February 6, 2	2018-02-06
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 9,822,058 - Toledo-Sherman , et al. November 21, 2	2017-11-21
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 9,649,310 - Dominguez , et al. May 16, 2	2017-05-16
Certain Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20160361312 - Dominguez; Celia ; et al.	2016-12-15
Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20160272611 - Dominguez; Celia ; et al.	2016-09-22
Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20160257674 - Dominguez; Celia ; et al.	2016-09-08
Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20160251318 - Courtney; Stephen Martin ; et al.	2016-09-01
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 9,428,464 - Courtney , et al. August 30, 2	2016-08-30
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof Grant 9,260,422 - Dominguez , et al. February 16, 2	2016-02-16
Transglutaminase Tg2 Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20150232420 - Dominguez; Celia ; et al.	2015-08-20
Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20150057238 - Toledo-Sherman; Leticia M. ; et al.	2015-02-26
Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof Grant 8,946,197 - Dominguez , et al. February 3, 2	2015-02-03
Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof Grant 8,889,716 - Prime , et al. November 18, 2	2014-11-18
Certain Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20140329816 - Dominguez; Celia ; et al.	2014-11-06
Kynurenine-3-monooxygenase Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20140329795 - Courtney; Stephen Martin ; et al.	2014-11-06
Transglutaminase Tg2 Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20130116216 - Dominguez; Celia ; et al.	2013-05-09
Transglutaminase Tg2 Inhibitors, Pharmaceutical Compositions, And Methods Of Use Thereof App 20120302539 - Prime; Michael ; et al.	2012-11-29
Heterocyclyl pyridyl sulfonamide derivatives, their manufacture and use as pharmaceutical agents Grant 7,939,532 - Brookfield , et al. May 10, 2	2011-05-10
Heterocyclyl Pyridyl Sulfonamide Derivatives, Their Manufacture And Use As Pharmaceutical Agents App 20100292247 - Brookfield; Frederick ; et al.	2010-11-18
Pentacyclic kinase inhibitors Grant 7,749,994 - Rawson , et al. July 6, 2	2010-07-06
Phthalazinone Pyrazole Derivatives, Their Manufacture And Use As Pharmaceutical Agents App 20090221599 - Boyd; Edward ; et al.	2009-09-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.